LIPELLA PHARMACEUTICALS INC's ticker is and the CUSIP is 53630L100. A total of 8 filers reported holding LIPELLA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,473 | -34.2% | 7,718 | +0.1% | 0.00% | – |
| Q1 2024 | $5,280 | -25.2% | 7,708 | +11.4% | 0.00% | – |
| Q4 2023 | $7,057 | -4.4% | 6,919 | +40.6% | 0.00% | – |
| Q3 2023 | $7,380 | +114.7% | 4,920 | +206.4% | 0.00% | – |
| Q2 2023 | $3,437 | +85825.0% | 1,606 | -27.6% | 0.00% | – |
| Q1 2023 | $4 | – | 2,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 9 | $19 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,421 | $5,181 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,606 | $3,437 | 0.00% |
| VANGUARD GROUP INC | 34,520 | $73,873 | 0.00% |